Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05852925 · ClinicalTrials.gov registry record · NA
Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers
A NA study of Blood Self-Collection for Clinical Diagnostic Assessments, sponsored by American Research Labs.
- Recruiting
- Registry status
- NA
- Development phase
- 2,500
- Enrollment target
- 1
- Study location
NCT05852925: Recruiting NA study of Blood Self-Collection for Clinical Diagnostic Assessments, sponsored by American Research Labs.
NCT05852925 is a NA study of Blood Self-Collection for Clinical Diagnostic Assessments that is actively recruiting participants, run by American Research Labs. The registered enrollment target is 2,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05852925, a NA study of Blood Self-Collection for Clinical Diagnostic Assessments, is actively recruiting participants, sponsored by American Research Labs.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarker analysis results from both specimen types will be compared for correlation.
Primary Outcome
Correlation between the venous blood sample with the Tasso+ blood sample for the biomarkers listed in the study description. The biomarkers are quantified or qualitatively measured using either Abbott Alinity ci-series, Siemens Dimension EXL, Siemens Immulite 2000 xpi, Dynex DSX Automated Elisa System, or an equivalent analyzer. Note: A biomarker collected from both venipuncture and Tasso+ methods will be analyzed using the same analyzer to avoid any bias that may arise from using different in
Conditions Studied
Interventions
- OTHER Traditional Venipuncture
- DEVICE Tasso+
Study Locations (1)
Florida
- American Research Labs - Atlantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05852925 shows while recruiting
NCT05852925 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).
The record links to 1 condition, with Blood Self-Collection for Clinical Diagnostic Assessments appearing as the primary indexed condition, and to 2 interventions - of which Traditional Venipuncture is the first listed.
NCT05852925 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05852925 about?
NCT05852925 is a clinical study titled "Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers". This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarke...
What is the current status of trial NCT05852925?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2023-07-25. Estimated completion is 2026-07.
What conditions does trial NCT05852925 study?
This clinical trial studies the following conditions: Blood Self-Collection for Clinical Diagnostic Assessments.
What interventions are being tested in trial NCT05852925?
The interventions under investigation include: Traditional Venipuncture (OTHER), Tasso+ (DEVICE).
Who is sponsoring clinical trial NCT05852925?
This trial is sponsored by American Research Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05852925 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05852925's enrollment target sits among peer trials
2,500 44th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI